1)日本糖尿病学会(編著):糖尿病治療ガイド2014-2015,文光堂,2014
2)Weng J, et al:Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes;A multicentre randomised parallel-group trial. Lancet 371:1753-1760, 2008
3)Bretzel RG, et al:Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents(APOLLO);An open randomised controlled trial. Lancet 371:1073-1084, 2008
4)Holman RR, et al:Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 357:1716-1730, 2007
5)Holman RR, et al:Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 361:1736-1747, 2009
6)American Diabetes Association:Standards of Medical Care in Diabetes─2015. Diabetes Care 38 Suppl:S1-S93, 2015
7)Shimoda S, et al:Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy. Endocr J 62:209-216, 2015
8)Cai X, et al:Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatment. PLoS ONE 7:e38962, 2012
9)Takamura T, et al:Factors associated with improvement of fasting plasma glucose level by mealtime dosing of a rapid-acting insulin analog in type 2 diabetes. Diabetes Res Clin Pract 75:278-284, 2007